Awakening gene therapy with Sleeping Beauty transposons - PubMed (original) (raw)
Review
Awakening gene therapy with Sleeping Beauty transposons
Jeffrey J Essner et al. Curr Opin Pharmacol. 2005 Oct.
Abstract
Sleeping Beauty transposons have the potential for use as chromosome-integrating vectors for non-viral gene therapy. Recent preclinical data from mouse models for human genetic disorders have shown efficacy for the Sleeping Beauty transposon system in the treatment of hemophilia, tyrosinemia type I, junctional epidermolysis bullosa and type 1 diabetes. Methods have also been developed to deliver Sleeping Beauty transposons to the lung, liver and tumors for treatments for cystic fibrosis, cardiovascular and metabolic diseases, and cancer. Recent studies characterizing site selection for integration and insertional mutagenesis indicate that the Sleeping Beauty transposon system may be a safer alternative than viral approaches for gene therapy.
Similar articles
- Applications of Sleeping Beauty transposons for nonviral gene therapy.
Liu H, Visner GA. Liu H, et al. IUBMB Life. 2007 Jun;59(6):374-9. doi: 10.1080/15216540701435722. IUBMB Life. 2007. PMID: 17613167 Review. - Liver-directed gene therapy using the sleeping beauty transposon system.
Belur LR, McIvor RS, Wilber A. Belur LR, et al. Methods Mol Biol. 2008;434:267-76. doi: 10.1007/978-1-60327-248-3_16. Methods Mol Biol. 2008. PMID: 18470650 - Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates.
Izsvák Z, Ivics Z, Plasterk RH. Izsvák Z, et al. J Mol Biol. 2000 Sep 8;302(1):93-102. doi: 10.1006/jmbi.2000.4047. J Mol Biol. 2000. PMID: 10964563 - Hyperactive transposase mutants of the Sleeping Beauty transposon.
Baus J, Liu L, Heggestad AD, Sanz S, Fletcher BS. Baus J, et al. Mol Ther. 2005 Dec;12(6):1148-56. doi: 10.1016/j.ymthe.2005.06.484. Epub 2005 Sep 8. Mol Ther. 2005. PMID: 16150650 - The Sleeping Beauty transposon toolbox.
Ammar I, Izsvák Z, Ivics Z. Ammar I, et al. Methods Mol Biol. 2012;859:229-40. doi: 10.1007/978-1-61779-603-6_13. Methods Mol Biol. 2012. PMID: 22367875 Review.
Cited by
- CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma.
Prommersberger S, Reiser M, Beckmann J, Danhof S, Amberger M, Quade-Lyssy P, Einsele H, Hudecek M, Bonig H, Ivics Z. Prommersberger S, et al. Gene Ther. 2021 Sep;28(9):560-571. doi: 10.1038/s41434-021-00254-w. Epub 2021 Apr 13. Gene Ther. 2021. PMID: 33846552 Free PMC article. Clinical Trial. - Intestinal Transit Time and Cortisol-Mediated Stress in Zebrafish.
Brady C, Denora M, Shannon I, Clark KJ, Rich A. Brady C, et al. Zebrafish. 2017 Oct;14(5):404-410. doi: 10.1089/zeb.2017.1440. Epub 2017 Jul 20. Zebrafish. 2017. PMID: 28727940 Free PMC article. - Biomaterial-Guided Gene Delivery for Musculoskeletal Tissue Repair.
Madrigal JL, Stilhano R, Silva EA. Madrigal JL, et al. Tissue Eng Part B Rev. 2017 Aug;23(4):347-361. doi: 10.1089/ten.TEB.2016.0462. Epub 2017 Mar 10. Tissue Eng Part B Rev. 2017. PMID: 28166711 Free PMC article. Review. - Generation of neuronal progenitor cells and neurons from mouse sleeping beauty transposon-generated induced pluripotent stem cells.
Klincumhom N, Pirity MK, Berzsenyi S, Ujhelly O, Muenthaisong S, Rungarunlert S, Tharasanit T, Techakumphu M, Dinnyes A. Klincumhom N, et al. Cell Reprogram. 2012 Oct;14(5):390-7. doi: 10.1089/cell.2012.0010. Epub 2012 Aug 23. Cell Reprogram. 2012. PMID: 22917491 Free PMC article. - The Sleeping Beauty transposon system: a non-viral vector for gene therapy.
Aronovich EL, McIvor RS, Hackett PB. Aronovich EL, et al. Hum Mol Genet. 2011 Apr 15;20(R1):R14-20. doi: 10.1093/hmg/ddr140. Epub 2011 Apr 1. Hum Mol Genet. 2011. PMID: 21459777 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical